| 前收市價 | 27.03 |
| 開市 | 27.01 |
| 買盤 | 26.85 x 800 |
| 賣出價 | 27.60 x 1100 |
| 今日波幅 | 26.49 - 27.33 |
| 52 週波幅 | 15.10 - 39.05 |
| 成交量 | |
| 平均成交量 | 2,045,492 |
| 市值 | 4.067B |
| Beta 值 (5 年，每月) | 2.02 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.60 |
| 業績公佈日 | 2024年4月30日 |
| 遠期股息及收益率 | 1.00 (3.66%) |
| 除息日 | 2024年2月23日 |
| 1 年預測目標價 | 31.44 |
ZacksChemours (CC) Up 2.9% Since Last Earnings Report: Can It Continue?
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Reuters
UPDATE 1-Chemours CFO Jonathan Lock steps down after financial revisions
Chemours said on Thursday its chief financial officer, Jonathan Lock, had resigned on April 23 after the chemical firm revised certain past financial results following an internal review. Earlier this year, the internal review showed manipulation by some of its senior management to meet free cash flow targets tied to their incentives, resulting in its top three executives, including Lock and CEO Mark Newman, being placed on administrative leave. The review had identified "material weaknesses" in the company's internal control over financial reporting and resulted in revisions of its balance sheet as of Dec. 31, 2022 and its cash flow statements for 2021 and 2022.
ZacksStepan Co. (SCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Stepan Co. (SCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
